Evidence map›Paper›PMID 38467428›Full record

ArticleJournal of the American Board of Family Medicine : JABFM2024

The Impact of the Medicaid Reimbursement Bump on Influenza Vaccination Rates Among US Teens: Evidence from the National Immunization Survey-Teen 2011-2020.

Felippe O Marcondes, Mary Price, Alex McDowell, Joseph P Newhouse, John Hsu, Vicki Fung

Abstract read
In one paragraph

Article in Journal of the American Board of Family Medicine : JABFM, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Felippe O MarcondesFrom the Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA (FOM); Mongan Institute Health Policy Research Center, Massachusetts General Hospital, Boston, MA (MP, AM, JH, VF); Department of Health Care Policy, Harvard Medical School, Boston, MA (JPN, JH); Department of Health Policy and Management, Harvard T. H. Chan School of Public Health (JPN); Harvard Kennedy School, Cambridge, MA (JPN); National Bureau of Economic Research, Cambridge, MA (JPN); Department of Medicine, Harvard Medical School, Boston, MA (AM, JH, VF). fmarcondes@mgh.harvard.edu.
Mary PriceFrom the Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA (FOM); Mongan Institute Health Policy Research Center, Massachusetts General Hospital, Boston, MA (MP, AM, JH, VF); Department of Health Care Policy, Harvard Medical School, Boston, MA (JPN, JH); Department of Health Policy and Management, Harvard T. H. Chan School of Public Health (JPN); Harvard Kennedy School, Cambridge, MA (JPN); National Bureau of Economic Research, Cambridge, MA (JPN); Department of Medicine, Harvard Medical School, Boston, MA (AM, JH, VF).
Alex McDowellFrom the Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA (FOM); Mongan Institute Health Policy Research Center, Massachusetts General Hospital, Boston, MA (MP, AM, JH, VF); Department of Health Care Policy, Harvard Medical School, Boston, MA (JPN, JH); Department of Health Policy and Management, Harvard T. H. Chan School of Public Health (JPN); Harvard Kennedy School, Cambridge, MA (JPN); National Bureau of Economic Research, Cambridge, MA (JPN); Department of Medicine, Harvard Medical School, Boston, MA (AM, JH, VF).
Joseph P NewhouseFrom the Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA (FOM); Mongan Institute Health Policy Research Center, Massachusetts General Hospital, Boston, MA (MP, AM, JH, VF); Department of Health Care Policy, Harvard Medical School, Boston, MA (JPN, JH); Department of Health Policy and Management, Harvard T. H. Chan School of Public Health (JPN); Harvard Kennedy School, Cambridge, MA (JPN); National Bureau of Economic Research, Cambridge, MA (JPN); Department of Medicine, Harvard Medical School, Boston, MA (AM, JH, VF).
John HsuFrom the Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA (FOM); Mongan Institute Health Policy Research Center, Massachusetts General Hospital, Boston, MA (MP, AM, JH, VF); Department of Health Care Policy, Harvard Medical School, Boston, MA (JPN, JH); Department of Health Policy and Management, Harvard T. H. Chan School of Public Health (JPN); Harvard Kennedy School, Cambridge, MA (JPN); National Bureau of Economic Research, Cambridge, MA (JPN); Department of Medicine, Harvard Medical School, Boston, MA (AM, JH, VF).
Vicki FungFrom the Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA (FOM); Mongan Institute Health Policy Research Center, Massachusetts General Hospital, Boston, MA (MP, AM, JH, VF); Department of Health Care Policy, Harvard Medical School, Boston, MA (JPN, JH); Department of Health Policy and Management, Harvard T. H. Chan School of Public Health (JPN); Harvard Kennedy School, Cambridge, MA (JPN); National Bureau of Economic Research, Cambridge, MA (JPN); Department of Medicine, Harvard Medical School, Boston, MA (AM, JH, VF).

Funding

AHRQ HHS R01 HS024725AHRQ HHS R01 HS025378
6 · The paper itself

Abstract

backgroundMany adolescents do not receive basic preventive care such as influenza vaccinations. The Affordable Care Act (ACA) temporarily increased Medicaid reimbursements for primary care services, including vaccine administration, in 2013 to 2014. The objective of this study is to assess the impact of reimbursement increases on influenza vaccination rates among adolescents with Medicaid.

methodsThis repeated cross-sectional study used a difference-in-difference approach to compare changes in annual influenza vaccination rates for 20,884 adolescents 13 to 17 years old covered by Medicaid with adequate provider-reported data in 18 states with larger extended (>$5, 2013 to 2019) versus larger temporary (2013 to 2014 only) versus smaller reimbursement changes. We used linear probability models with individual-level random effects, adjusting for state and individual characteristics and annual time trends to assess the impact of a Medicaid vaccine administration reimbursement increase on annual influenza vaccination.

resultsMean Medicaid reimbursements for vaccine administration doubled from 2011 to 2013 to 2014 (eg, from $11 to $22 for CPT 90460). States with smaller reimbursement changes had higher mean reimbursements and higher adjusted vaccination rates at baseline (2011) compared with states with larger temporary and extended reimbursement changes. The reimbursement change was not associated with increases in influenza vaccination rates. DISCUSSION: Influenza vaccination rates were low among adolescents with Medicaid throughout the study period, particularly in states with lower Medicaid reimbursement levels before the ACA.

conclusionThat reimbursement increases were not associated with higher vaccination rates suggests additional efforts are needed to improve influenza vaccination rates in this population.

Indexed as

Influenza, HumanVaccinesAdolescentCross-Sectional StudiesHumansImmunizationMedicaidPatient Protection and Affordable Care ActUnited StatesVaccinationVaccinesAdolescentAffordable Care ActCross-Sectional StudiesHealth PolicyImmunizationInfluenzaMedicaid

Identifiers

PMID38467428
PMCPMC12183506

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.